Koyfin Home > Directory > Health Care > Abeona Therapeutics

Abeona Therapeutics Price Chart ABEO

Historical daily share price chart and data for Abeona Therapeutics since 2006 adjusted for splits and dividends. The latest closing price for Abeona Therapeutics as of October 19, 2020 is $1.31.
  • In 2020 the stock opened at $3.59 and closed at $1.31 for a loss of -174% YTD.
  • In 2019 the stock opened at $7.00 and closed at $3.27 for a loss of -114%.
  • In 2018 the stock opened at $15.90 and closed at $7.14 for a loss of -123%.
  • In 2017 the stock opened at $5.10 and closed at $15.85 for a gain of 68%.
View Chart On Koyfin

Abeona Therapeutics Summary

Stock Symbol: ABEO

Abeona Therapeutics Company Info

Abeona Therapeutics Inc., a clinical-stage biopharmaceutical company, develops gene and cell therapies for life-threatening rare genetic diseases. Its lead programs include EB-101, an autologous, gene-corrected cell therapy for recessive dystrophic epidermolysis bullosa; ABO-102, an adeno-associated virus-based gene therapy for Sanfilippo syndrome type A; and ABO-101, an AAV-based gene therapy for Sanfilippo syndrome type B. The company also develops ABO-202 and ABO-201, which are AAV-based gene therapies for the CLN1 and CLN3 forms of Batten disease; ABO-401 for the treatment of cystic fibrosis; and ABO-5OX for the treatment of genetic eye disorders. In addition, it is developing AAV-based gene therapy through its AIM vector platform programs. Abeona Therapeutics Inc. has a license agreement with REGENXBIO Inc. for the development and commercialization of gene therapies for the treatment of MPS IIIA, MPS IIIB, CLN1 disease, and CLN3 disease. The company was formerly known as PlasmaTech Biopharmaceuticals, Inc. and changed its name to Abeona Therapeutics Inc. in June 2015. Abeona Therapeutics Inc. was incorporated in 1974 and is headquartered in New York, New York.
Market Cap
Dividend Yield
0 %
Beta vs SPX
Short Interest
222.39 %
30D Volatility
Hedge Fund Held
0 %

Last 10 Days of ABEO Prices